These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 300484)

  • 21. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. II. Correlation between derivatization of H-2 antigens with trinitrophenyl and the ability of trinitrophenyl-modified cells to react functionally to the CML assay.
    Forman J; Vitetta ES; Hart DA
    J Immunol; 1977 Mar; 118(3):803-8. PubMed ID: 66273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
    Platsoucas CD
    Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
    Sherman L; Mescher MF; Burakoff SJ
    J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The induction of cytolytic T lymphocytes with specificity for p-azophenylarsonate coupled syngeneic cells.
    Sherman LA; Burakoff SJ; Benacerraf B
    J Immunol; 1978 Oct; 121(4):1432-6. PubMed ID: 81234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.
    Forman J; Vitetta ES; Hart DA; Klein J
    J Immunol; 1977 Mar; 118(3):797-802. PubMed ID: 66272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts.
    Altman A; Cohen IR
    Eur J Immunol; 1976 Jul; 5(7):437-44. PubMed ID: 135686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.
    Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP
    J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.
    Shearer GM
    Eur J Immunol; 1974 Aug; 4(8):527-33. PubMed ID: 4547153
    [No Abstract]   [Full Text] [Related]  

  • 31. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
    Mills GB; Paetkau V
    J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT; Herberman RB
    Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
    [No Abstract]   [Full Text] [Related]  

  • 34. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens.
    Ennis FA; Martin WJ; Verbonitz MW; Butchko GM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3006-10. PubMed ID: 70788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Confirmation of genetic control of response to trinitrophenyl-modified H-2 antigens by the use of anti-H-2 and anti-Ia antibodies.
    Schmitt-Verhulst AM; Sachs DH; Shearer GM
    J Exp Med; 1976 Jan; 143(1):211-7. PubMed ID: 1244419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts.
    Warnatz H; Krapf F
    J Immunol; 1976 Sep; 117(3):981-5. PubMed ID: 182884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.
    Wilson DB; Lindahl KF; Wilson DH; Sprent J
    J Exp Med; 1977 Aug; 146(2):361-7. PubMed ID: 301550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.